Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Beral, V, Reeves, G
التنسيق:	Conference item
منشور في:	1998

مواد مشابهة

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
حسب: Beral, V
منشور في: (1996)

Childbearing, oral contraceptive use, and breast cancer.
حسب: Beral, V, وآخرون
منشور في: (1993)

CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER
حسب: Beral, V, وآخرون
منشور في: (1993)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
حسب: Beral, V
منشور في: (1997)

Breast cancer and hormonal contraceptives: Further results
حسب: Calle, E, وآخرون
منشور في: (1996)

Breast cancer trends in women in Sweden, the UK, and the USA in relation to their past use of oral contraceptives
حسب: Beral, V, وآخرون
منشور في: (1996)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case–control study and meta-analysis
حسب: Fitzpatrick, D, وآخرون
منشور في: (2023)

Breast cancer and oral contraceptives--the evidence so far.
حسب: Reeves, G
منشور في: (1996)

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
حسب: Cancer, C
منشور في: (1996)

Breast Cancer Risk in Relation to Use of Combined and Progestogen-Only Contraceptives: Results from a UK Record-Linkage Study
حسب: Reeves, G, وآخرون
منشور في: (2012)

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
حسب: Luciano de Melo Pompei, وآخرون
منشور في: (2020-06-01)

Breast cancer and hormone exposure - Reply
حسب: Beral, V, وآخرون
منشور في: (1996)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
حسب: Banks, E, وآخرون
منشور في: (2004)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
حسب: Danielle Fitzpatrick, وآخرون
منشور في: (2023-03-01)

Meta-analysis: Use of combined oral contraceptives in the past 10 years is associated with an increased risk for breast cancer
حسب: Beral, V
منشور في: (1996)

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
حسب: I. V. Vуsotskaya, وآخرون
منشور في: (2019-09-01)

Oral contraceptives and breast cancer.
حسب: McPherson, K, وآخرون
منشور في: (1983)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
حسب: Banks, E, وآخرون
منشور في: (2004)

Menopausal hormone therapy and 20-year breast cancer mortality
حسب: Beral, V, وآخرون
منشور في: (2019)

AGE-SPECIFIC DIFFERENCES IN THE RELATION BETWEEN ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
حسب: Wingo, P, وآخرون
منشور في: (1990)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
حسب: Wingo, P, وآخرون
منشور في: (1993)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
حسب: Wingo, P, وآخرون
منشور في: (1991)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
حسب: Beral, V, وآخرون
منشور في: (1997)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
حسب: Beral, V, وآخرون
منشور في: (2011)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
حسب: Calle, E, وآخرون
منشور في: (1996)

Impact of hormone replacement therapy on breast cancer
حسب: Gathani, T, وآخرون
منشور في: (2010)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
حسب: Beral, V, وآخرون
منشور في: (2003)

Variations in the Prevalence of Risk Factors for Breast Cancer in Different Ethnic Groups in the Million Women Study
حسب: Gathani, T, وآخرون
منشور في: (2012)

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
حسب: Beral, V, وآخرون
منشور في: (2008)

Breast cancer and hormone-replacement therapy in the Million Women Study.
حسب: Beral, V
منشور في: (2003)

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.
حسب: Beral, V, وآخرون
منشور في: (2004)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
حسب: Beral, V, وآخرون
منشور في: (2004)

Oral contraceptives and the small increased risk of breast cancer
حسب: Hunter, D
منشور في: (2017)

BREAST-CANCER AND THE ESTROGEN CONTENT OF ORAL-CONTRACEPTIVES - REPLY
حسب: Mcpherson, K, وآخرون
منشور في: (1984)

Oral contraceptives and the small increased risk of breast cancer
حسب: Hunter, D
منشور في: (2017)

Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women
حسب: Urban, M, وآخرون
منشور في: (2013)

Early oral contraceptive use and breast cancer: results of another case-control study.
حسب: McPherson, K, وآخرون
منشور في: (1987)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
حسب: Reeves, G, وآخرون
منشور في: (2006)

Oral contraceptives and breast cancer. A prospective cohort study.
حسب: Lipnick, R, وآخرون
منشور في: (1986)

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
حسب: Satish S, وآخرون
منشور في: (2023-03-01)